Evo 2 now includes information from humans, plants, and other eukaryotic species to expand its capabilities in generative functional genomics.

The 2nd ADC Payload Summit (May 6-8 | Boston, MA). This is the first and only conference exclusively focusing on ADC payloads ...

Using a new technology and computational method, researchers have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers.

The new technology – Cleavage Under Targeted Accessible Chromatin (CUTAC) – focuses on small, fragmented DNA non-coding ...